ANIX
Price
$3.18
Change
-$0.02 (-0.62%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
103.08M
59 days until earnings call
EYPT
Price
$9.86
Change
-$0.31 (-3.05%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
677.11M
14 days until earnings call
Interact to see
Advertisement

ANIX vs EYPT

Header iconANIX vs EYPT Comparison
Open Charts ANIX vs EYPTBanner chart's image
Anixa Biosciences
Price$3.18
Change-$0.02 (-0.62%)
Volume$255
Capitalization103.08M
EyePoint Pharmaceuticals
Price$9.86
Change-$0.31 (-3.05%)
Volume$9.86K
Capitalization677.11M
ANIX vs EYPT Comparison Chart in %
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. EYPT commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and EYPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (ANIX: $3.20 vs. EYPT: $9.84)
Brand notoriety: ANIX and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 111% vs. EYPT: 64%
Market capitalization -- ANIX: $103.08M vs. EYPT: $677.11M
ANIX [@Biotechnology] is valued at $103.08M. EYPT’s [@Biotechnology] market capitalization is $677.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANIX and EYPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 4 TA indicator(s) are bullish while EYPT’s TA Score has 4 bullish TA indicator(s).

  • ANIX’s TA Score: 4 bullish, 5 bearish.
  • EYPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ANIX and EYPT are a bad buy in the short-term.

Price Growth

ANIX (@Biotechnology) experienced а +1.91% price change this week, while EYPT (@Biotechnology) price change was -1.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.

Reported Earning Dates

ANIX is expected to report earnings on Sep 12, 2025.

EYPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($677M) has a higher market cap than ANIX($103M). ANIX YTD gains are higher at: 37.931 vs. EYPT (32.081). ANIX has higher annual earnings (EBITDA): -13.11M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. ANIX (15.6M). ANIX has less debt than EYPT: ANIX (221K) vs EYPT (24.1M). EYPT has higher revenues than ANIX: EYPT (56M) vs ANIX (0).
ANIXEYPTANIX / EYPT
Capitalization103M677M15%
EBITDA-13.11M-144.55M9%
Gain YTD37.93132.081118%
P/E RatioN/AN/A-
Revenue056M-
Total Cash15.6M318M5%
Total Debt221K24.1M1%
FUNDAMENTALS RATINGS
ANIX vs EYPT: Fundamental Ratings
ANIX
EYPT
OUTLOOK RATING
1..100
5864
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
8691
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4638
P/E GROWTH RATING
1..100
10017
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYPT's Valuation (60) in the Pharmaceuticals Major industry is in the same range as ANIX (74) in the Computer Peripherals industry. This means that EYPT’s stock grew similarly to ANIX’s over the last 12 months.

ANIX's Profit vs Risk Rating (86) in the Computer Peripherals industry is in the same range as EYPT (91) in the Pharmaceuticals Major industry. This means that ANIX’s stock grew similarly to EYPT’s over the last 12 months.

ANIX's SMR Rating (97) in the Computer Peripherals industry is in the same range as EYPT (97) in the Pharmaceuticals Major industry. This means that ANIX’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as ANIX (46) in the Computer Peripherals industry. This means that EYPT’s stock grew similarly to ANIX’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for ANIX (100) in the Computer Peripherals industry. This means that EYPT’s stock grew significantly faster than ANIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXEYPT
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JBAFX30.37N/A
N/A
JHancock Balanced R4
GLCUX35.34N/A
N/A
Goldman Sachs Large Cap Gr Insghts R6
MRJCX10.75N/A
N/A
Morgan Stanley Multi-Asset Real Return C
MAIHX19.08N/A
N/A
Morgan Stanley Inst Passport ovrs eq IR
FIVUX35.27-0.61
-1.70%
Macquarie Opportunity Instl

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with LGND. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
N/A
LGND - ANIX
33%
Loosely correlated
-2.06%
GLUE - ANIX
31%
Poorly correlated
-0.57%
VERA - ANIX
31%
Poorly correlated
-2.44%
CGON - ANIX
31%
Poorly correlated
-3.67%
REPL - ANIX
31%
Poorly correlated
+9.93%
More

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-3.24%
OCUL - EYPT
59%
Loosely correlated
-1.60%
LYRA - EYPT
58%
Loosely correlated
-2.64%
RXRX - EYPT
55%
Loosely correlated
-1.14%
CRSP - EYPT
55%
Loosely correlated
-6.54%
ATHE - EYPT
54%
Loosely correlated
-3.46%
More